DOI: 10.1001/jamaneurol.2023.4719 ISSN: 2168-6149

Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers

Wagner S. Brum, Kieran F. Docherty, Nicholas J. Ashton, Henrik Zetterberg, Oskar Hansson, John J. V. McMurray, Kaj Blennow
  • Neurology (clinical)

This exploratory analysis of a randomized clinical trial evaluates the effect of neprilysin inhibition on Alzheimer disease blood biomarkers in patients with heart disease.

More from our Archive